Get 20% lifetime commission for referring investors to digrin.com
here.
Jupiter Neurosciences, Inc. ( JUNS) - Key Metrics
JUNS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.04 | -$4.08 | -$4.12 | -$4.12 |
| 2026Q1 | $0.04 | -$4.39 | -$3.05 | -$3.05 |
| 2025Q4 | $0.05 | -$5.61 | -$5.16 | -$5.16 |
| 2025Q3 | $0 | -$5.04 | -$2.54 | -$2.54 |
| 2025Q2 | $0 | -$5.09 | -$1.87 | -$1.87 |
JUNS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.98 |
| 2026Q1 | 0% | -1.61 |
| 2025Q4 | 0% | -3.41 |
| 2025Q3 | 0% | -6.29 |
| 2025Q2 | 0% | -3.76 |
JUNS
Price: $2.90
52 week price:
Earnings Per Share: -18.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.2 million